As of Aug 31
| -2.92 / -3.08%|
The 4 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 196.00, with a high estimate of 285.00 and a low estimate of 122.00. The median estimate represents a +113.23% increase from the last price of 91.92.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.